18 May 2021
Proteome Sciences plc
("Proteome Sciences" or the "Company")
Change of Registered Office
The directors of Proteome Sciences announce that the Company's registered office address has changed to 5 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey, KT15 2HJ with immediate effect.
For further information:
Proteome Sciences plc Dr Mariola Soehngen, Chief Executive Officer & |
|
Dr Ian Pike, Chief Scientific Officer
|
Tel: +44 (0)20 7043 2116 |
Allenby Capital Limited (AIM Nominated Adviser & Broker) |
|
John Depasquale / Jeremy Porter |
Tel: +44 (0) 20 3328 5656 |
About Proteome Sciences plc. ( www.proteomics.com )
Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.
The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.